Innovation backed by scientific evidence
Setting new gold standards in neurodegenerative disorder assessment
Indivi is developing and validating user-friendly, reliable, and responsive instruments spanning across all key measurement concepts of interest (COI), focusing on Multiple Sclerosis, Parkinson's disease, Alzheimer’s disease, and related dementias.
Through end-to-end collaborations with bio-pharmaceutical companies and RC2NB, Indivi is spearheading the use of advanced computational and statistical modelling methods to potentially yield more precise measures of progression of neurodegenerative disorders with improved signal-to-noise properties. By bringing together Konectomᵀᴹ (licensed from Biogen) and dreaMSᴹᴰ, Indivi is able to offer a best-in-class digital measurement technology solution.